Market closedNon-fractional
Eton Pharmaceuticals/ETON
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Eton Pharmaceuticals
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Ticker
ETON
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Deer Park, United States
Employees
30
Website
www.etonpharma.com
ETON Metrics
BasicAdvanced
$85M
Market cap
101.16
P/E ratio
$0.03
EPS
1.19
Beta
-
Dividend rate
Price and volume
Market cap
$85M
Beta
1.19
Financial strength
Current ratio
1.586
Quick ratio
1.366
Total debt to equity
32.961
Interest coverage (TTM)
0.52%
Management effectiveness
Return on assets (TTM)
1.24%
Return on equity (TTM)
6.83%
Valuation
Price to earnings (TTM)
101.161
Price to revenue (TTM)
2.488
Price to book
5.44
Price to tangible book (TTM)
9.26
Price to free cash flow (TTM)
26.397
Growth
Revenue change (TTM)
40.71%
Earnings per share change (TTM)
-113.02%
3-year revenue growth
42.57%
3-year earnings per share growth
-62.32%
What the Analysts think about ETON
Analyst Ratings
Majority rating from 1 analysts.
ETON Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$7.9M
8.22%
Net income
-$800K
-63.64%
Profit margin
-10.12%
-66.41%
ETON Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.18
-$0.02
-$0.09
-$0.03
-
Expected
-$0.09
-$0.10
-$0.04
-$0.07
-$0.07
Surprise
-300.00%
-80.00%
125.00%
-57.14%
-
ETON News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Eton Pharmaceuticals stock?
Eton Pharmaceuticals (ETON) has a market cap of $85M as of July 06, 2024.
What is the P/E ratio for Eton Pharmaceuticals stock?
The price to earnings (P/E) ratio for Eton Pharmaceuticals (ETON) stock is 101.16 as of July 06, 2024.
Does Eton Pharmaceuticals stock pay dividends?
No, Eton Pharmaceuticals (ETON) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Eton Pharmaceuticals dividend payment date?
Eton Pharmaceuticals (ETON) stock does not pay dividends to its shareholders.
What is the beta indicator for Eton Pharmaceuticals?
Eton Pharmaceuticals (ETON) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Eton Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.